BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23810334)

  • 21. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Iversen LH; Rasmussen PC; Laurberg S
    Br J Surg; 2013 Jan; 100(2):285-92. PubMed ID: 23124619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
    J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
    Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
    J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.
    Kianmanesh R; Scaringi S; Sabate JM; Castel B; Pons-Kerjean N; Coffin B; Hay JM; Flamant Y; Msika S
    Ann Surg; 2007 Apr; 245(4):597-603. PubMed ID: 17414609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
    Pocard M; Boige V
    Bull Cancer; 2005 Feb; 92(2):151-4. PubMed ID: 15749644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
    Chua TC; Pelz JO; Kerscher A; Morris DL; Esquivel J
    Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.
    Glockzin G; von Breitenbuch P; Schlitt HJ; Piso P
    J Surg Oncol; 2013 May; 107(6):574-8. PubMed ID: 22833286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Weber T; Roitman M; Link KH
    Clin Colorectal Cancer; 2012 Sep; 11(3):167-76. PubMed ID: 22397952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.
    Verwaal VJ; Boot H; Aleman BM; van Tinteren H; Zoetmulder FA
    Ann Surg Oncol; 2004 Apr; 11(4):375-9. PubMed ID: 15070596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an Asian perspective.
    Tan WJ; Wong JF; Chia CS; Tan GH; Soo KC; Teo MC
    Ann Surg Oncol; 2013 Dec; 20(13):4219-23. PubMed ID: 24008554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Verwaal VJ; van Tinteren H; van Ruth S; Zoetmulder FA
    Br J Surg; 2004 Jun; 91(6):739-46. PubMed ID: 15164445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
    Chua TC; Quinn LE; Zhao J; Morris DL
    J Surg Oncol; 2013 Aug; 108(2):81-8. PubMed ID: 23737041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
    Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
    Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
    Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
    Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.
    Klaver CE; Musters GD; Bemelman WA; Punt CJ; Verwaal VJ; Dijkgraaf MG; Aalbers AG; van der Bilt JD; Boerma D; Bremers AJ; Burger JW; Buskens CJ; Evers P; van Ginkel RJ; van Grevenstein WM; Hemmer PH; de Hingh IH; Lammers LA; van Leeuwen BL; Meijerink WJ; Nienhuijs SW; Pon J; Radema SA; van Ramshorst B; Snaebjornsson P; Tuynman JB; Te Velde EA; Wiezer MJ; de Wilt JH; Tanis PJ
    BMC Cancer; 2015 May; 15():428. PubMed ID: 26003804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
    Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
    Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
    de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
    Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of definitive stoma after surgery for peritoneal malignancy in 958 patients: comparative study between complete cytoreductive surgery and maximal tumor debulking.
    Riss S; Chandrakumaran K; Dayal S; Cecil TD; Mohamed F; Moran BJ
    Eur J Surg Oncol; 2015 Mar; 41(3):392-5. PubMed ID: 25238953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].
    Kavanagh M; Ouellet JF;
    Bull Cancer; 2006 Sep; 93(9):867-74. PubMed ID: 16980229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
    Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
    Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.